Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial - Concepedia

Concepedia

Publication | Open Access

Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial

DOI Full Paper Access

475

Citations

26

References

2020

Year

Yang Cao, Jia Wei, Liang Zou, Tiebin Jiang, Gaoxiang Wang, Liting Chen, Liang Huang, Fankai Meng, Lifang Huang, Na Wang,

Journal of Allergy and Clinical Immunology

References

	Year	Citations

Page 1